Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Gastroparesis Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Gastroparesis Drugsmarket, defines the market attractiveness level of Gastroparesis Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Gastroparesis Drugs industry, describes the types of Gastroparesis Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gastroparesis Drugs market and the development prospects and opportunities of Gastroparesis Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gastroparesis Drugs market in Chapter 13.
By Player:
Johnson & Johnson
Teva Pharmaceutical Industries
Evoke Pharma
Theravance Biopharma
Cadila Pharmaceuticals
Valeant
GlaxoSmithKline
By Type:
Prokinetic Agents
Antiemetic Agents
Botulinum Toxin Injection
Other
By End-User:
Diabetic Gastroparesis
Idiopathic Gastroparesis
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Gastroparesis Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Gastroparesis Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Gastroparesis Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Gastroparesis Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Gastroparesis Drugs Market Analysis and Outlook to 2022
-
7.1 Global Gastroparesis Drugs Consumption (2017-2022)
-
7.2 United States Gastroparesis Drugs Consumption (2017-2022)
-
7.3 Europe Gastroparesis Drugs Consumption (2017-2022)
-
7.4 China Gastroparesis Drugs Consumption (2017-2022)
-
7.5 Japan Gastroparesis Drugs Consumption (2017-2022)
-
7.6 India Gastroparesis Drugs Consumption (2017-2022)
-
7.7 South Korea Gastroparesis Drugs Consumption (2017-2022)
8 Region and Country-wise Gastroparesis Drugs Market Analysis and Outlook to 2028
-
8.1 Global Gastroparesis Drugs Consumption Forecast (2022-2028)
-
8.2 United States Gastroparesis Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Gastroparesis Drugs Consumption Forecast (2022-2028)
-
8.4 China Gastroparesis Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Gastroparesis Drugs Consumption Forecast (2022-2028)
-
8.6 India Gastroparesis Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Gastroparesis Drugs Consumption Forecast (2022-2028)
9 Global Gastroparesis Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Gastroparesis Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Prokinetic Agents Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Antiemetic Agents Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Botulinum Toxin Injection Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Gastroparesis Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Diabetic Gastroparesis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Idiopathic Gastroparesis Consumption and Growth Rate (2017-2022)
10 Global Gastroparesis Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Gastroparesis Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Prokinetic Agents Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Antiemetic Agents Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Botulinum Toxin Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Gastroparesis Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Diabetic Gastroparesis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Idiopathic Gastroparesis Consumption Forecast and Growth Rate (2022-2028)
11 Global Gastroparesis Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Gastroparesis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Gastroparesis Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Gastroparesis Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Gastroparesis Drugs Market Competitive Analysis
-
14.1 Johnson & Johnson
-
14.1.1 Johnson & Johnson Company Details
-
14.1.2 Johnson & Johnson Gastroparesis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson & Johnson Gastroparesis Drugs Product and Service
-
14.2 Teva Pharmaceutical Industries
-
14.2.1 Teva Pharmaceutical Industries Company Details
-
14.2.2 Teva Pharmaceutical Industries Gastroparesis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Teva Pharmaceutical Industries Gastroparesis Drugs Product and Service
-
14.3 Evoke Pharma
-
14.3.1 Evoke Pharma Company Details
-
14.3.2 Evoke Pharma Gastroparesis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Evoke Pharma Gastroparesis Drugs Product and Service
-
14.4 Theravance Biopharma
-
14.4.1 Theravance Biopharma Company Details
-
14.4.2 Theravance Biopharma Gastroparesis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Theravance Biopharma Gastroparesis Drugs Product and Service
-
14.5 Cadila Pharmaceuticals
-
14.5.1 Cadila Pharmaceuticals Company Details
-
14.5.2 Cadila Pharmaceuticals Gastroparesis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Cadila Pharmaceuticals Gastroparesis Drugs Product and Service
-
14.6 Valeant
-
14.6.1 Valeant Company Details
-
14.6.2 Valeant Gastroparesis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Valeant Gastroparesis Drugs Product and Service
-
14.7 GlaxoSmithKline
-
14.7.1 GlaxoSmithKline Company Details
-
14.7.2 GlaxoSmithKline Gastroparesis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GlaxoSmithKline Gastroparesis Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Gastroparesis Drugs
-
Figure Gastroparesis Drugs Picture
-
Table Global Gastroparesis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gastroparesis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gastroparesis Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Gastroparesis Drugs Consumption by Country (2017-2022)
-
Figure United States Gastroparesis Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Gastroparesis Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Gastroparesis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Gastroparesis Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Gastroparesis Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gastroparesis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Gastroparesis Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Gastroparesis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gastroparesis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Gastroparesis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gastroparesis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gastroparesis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gastroparesis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prokinetic Agents Consumption and Growth Rate (2017-2022)
-
Figure Global Antiemetic Agents Consumption and Growth Rate (2017-2022)
-
Figure Global Botulinum Toxin Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetic Gastroparesis Consumption and Growth Rate (2017-2022)
-
Figure Global Idiopathic Gastroparesis Consumption and Growth Rate (2017-2022)
-
Figure Global Prokinetic Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antiemetic Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Botulinum Toxin Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetic Gastroparesis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Idiopathic Gastroparesis Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Gastroparesis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Gastroparesis Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Gastroparesis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Gastroparesis Drugs Product and Service
-
Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Gastroparesis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Gastroparesis Drugs Product and Service
-
Table Evoke Pharma (Foundation Year, Company Profile and etc.)
-
Table Evoke Pharma Gastroparesis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Evoke Pharma Gastroparesis Drugs Product and Service
-
Table Theravance Biopharma (Foundation Year, Company Profile and etc.)
-
Table Theravance Biopharma Gastroparesis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Theravance Biopharma Gastroparesis Drugs Product and Service
-
Table Cadila Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Cadila Pharmaceuticals Gastroparesis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cadila Pharmaceuticals Gastroparesis Drugs Product and Service
-
Table Valeant (Foundation Year, Company Profile and etc.)
-
Table Valeant Gastroparesis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Gastroparesis Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Gastroparesis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Gastroparesis Drugs Product and Service
-
